Literature DB >> 1641246

Transport of isometamidium (Samorin) by drug-resistant and drug-sensitive Trypanosoma congolense.

I A Sutherland1, A Mounsey, P H Holmes.   

Abstract

The uptake kinetics of a 14C-labelled trypanocidal compound isometamidium chloride (Samorin, RMB Animal Health Ltd, UK) was measured in drug-resistant and drug-sensitive Trypanosoma congolense. It was established that drug uptake was significantly more rapid and quantitatively greater in drug-sensitive parasites. There was clear evidence that drug uptake in both the resistant and sensitive trypanosomes was by a specific, receptor-mediated process. This specific drug transport was energy-dependent, being sensitive to metabolic inhibition with SHAM/glycerol. Significant differences in drug transport were observed which could be correlated with resistance to isometamidium. The optimal pH for drug accumulation was lowered in the resistant trypanosomes; this finding, along with an observed change in specificity for the related compound homidium bromide, suggested that the specific receptor for isometamidium is altered in the resistant trypanosomes, possibly resulting in a reduction in drug uptake. In addition to these alterations in drug uptake, efflux of isometamidium also appears to occur in the resistant trypanosomes. Both a reduction in incubation temperature and metabolic inhibition increased the level of trypanosome-associated isometamidium in the resistant parasites. This was in contrast to observations using drug-sensitive parasites. Furthermore, the addition of calcium flux-modulating agents to the incubation medium also resulted in an increase in accumulation by the resistant parasites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641246     DOI: 10.1017/s0031182000063721

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  8 in total

1.  Modulation of mitochondrial electrical potential: a candidate mechanism for drug resistance in African trypanosomes.

Authors:  J M Wilkes; W Mulugeta; C Wells; A S Peregrine
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

2.  Cross-resistance associated with development of resistance to isometamidium in a clone of Trypanosoma congolense.

Authors:  A S Peregrine; M A Gray; S K Moloo
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  Resistance to trypanocidal drugs in cattle populations of Zambezia Province, Mozambique.

Authors:  Fernando Chanisso Mulandane; José Fafetine; Jan Van Den Abbeele; Peter-Henning Clausen; Antje Hoppenheit; Giuliano Cecchi; Marinda Oosthuizen; Vincent Delespaux; Luis Neves
Journal:  Parasitol Res       Date:  2017-12-20       Impact factor: 2.289

4.  Fluorescence analysis of the interaction of isometamidium with Trypanosoma congolense.

Authors:  D Zilberstein; J Wilkes; H Hirumi; A S Peregrine
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

5.  The accumulation and compartmentalization of isometamidium chloride in Trypanosoma congolense, monitored by its intrinsic fluorescence.

Authors:  J M Wilkes; A S Peregrine; D Zilberstein
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

Review 6.  The animal trypanosomiases and their chemotherapy: a review.

Authors:  Federica Giordani; Liam J Morrison; Tim G Rowan; Harry P DE Koning; Michael P Barrett
Journal:  Parasitology       Date:  2016-10-10       Impact factor: 3.234

7.  Genomic analysis of Isometamidium Chloride resistance in Trypanosoma congolense.

Authors:  Eliane Tihon; Hideo Imamura; Frederik Van den Broeck; Lieve Vermeiren; Jean-Claude Dujardin; Jan Van Den Abbeele
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-10-06       Impact factor: 4.077

8.  The individual components of commercial isometamidium do not possess stronger trypanocidal activity than the mixture, nor bypass isometamidium resistance.

Authors:  Anthonius A Eze; John Igoli; Alexander I Gray; Graham G Skellern; Harry P De Koning
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-01-21       Impact factor: 4.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.